Short communication
Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase

https://doi.org/10.1016/j.molbiopara.2005.02.016Get rights and content

Section snippets

Acknowledgement

Expression system for human TS was kindly provided by D.D. Banerjee of the University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA. This work was supported by NIH grants (AI26912 and AI60360) and the UW Keck Center for functional genomics. PKR is an Ellison Medical Foundation Senior Scholar in Global Infectious Diseases.

First page preview

First page preview
Click to open first page preview

References (24)

  • L. Jiang et al.

    Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum

    Antimicrob Agents Chemother

    (2000)
  • H.A. Ingraham et al.

    DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate

    Biochemistry

    (1986)
  • Cited by (6)

    • Perturbation of genome integrity to fight pathogenic microorganisms

      2017, Biochimica et Biophysica Acta - General Subjects
      Citation Excerpt :

      The fusion of the two proteins facilitates dihydrofolate elimination through metabolic channeling and allows sufficient coordinate control of folate metabolizing enzymes, which might represent a biological advantage of such bifunctional DHFR–TSs [156]. The junction of the two proteins is generally not considered as the source of differences in drug actions, which is rather assigned to the sequence diversity [157,158]. Although this flexible linker does not influence the action of classical antifolates it might be a subject of specific inhibitor design, since it modulates enzyme activity in some specific cases [159,160].

    • Structural biology of plasmodial proteins

      2007, Current Opinion in Structural Biology
    View full text